The Cardiopathic Features and Analysis of Risk Factors in the Elderly Diabetic
Information source: Third Military Medical University
Information obtained from ClinicalTrials.gov on October 19, 2009 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Two-Dimensional Echocardiography
Phase: N/A
Status: Recruiting
Sponsored by: Third Military Medical University Official(s) and/or principal investigator(s): Chen Bing, doctor, Study Director, Affiliation: Endocrine Department, the south west Hospital of the Third Military Medical University
Overall contact: Wu Qinan, master, Phone: 13452867542, Email: wqn11@126.com
Summary
Objectives: To investigate the cardiac condition of the diabetic patients in our hospital in
order to seek for the new diagnostic method of warning its cardiovascular complications in
early times.
Methods: 317 diabetic patients in our hospital from January in 2004 to July in 2008 were
divided into 2 groups: group A (106 patients whose age ranged from (31-59) and group B (211
patients whose age ranged from (60-90). The height, weight, blood glucose, glycosylated
hemoglobin, lipid, blood pressure, course of disease, ejection fraction (EF), fractional
shortening(FS), diameter of left ventricle in late diastolic stage(LVEDd), the thickness of
the ventricular septa(IVSDand the posterior wall of the right ventricle in late diastolic
stage (LVPWd)were recorded respectively. Left ventricular mass index (LVMI), relative wall
thickness (RWT) were calculated and High-sensitive C-reactive protein (HsCRP), homocysteine
and TNF-α were detected. Multifactor logistic regression was made based on the comparison
and contrast between all indexes to analyze the correlations between age and the positive
indexes.
Clinical Details
Official title: The Cardiopathic Features and Analysis of Risk Factors in the Elderly Diabetic
Study design: Cohort, Prospective
Primary outcome: the gender, height, weight, blood pressure, course of the disease of each patient was recorded
Secondary outcome: Left ventricular mass index (LVMI), relative wall thickness (RWT) were calculated and High-sensitive C-reactive protein (HsCRP), homocysteine and TNF-α were detected
Detailed description:
Diabetes is one of the commonly seen health hazards in modern times. According to
statistics, 70% people with diabetes have died of cardiovascular diseases.
Framingham `s study has proven the increase of the congestive heart-failure (2. 4: 1 in male
patients and5: 1 in female patients), which has no association with the age, hypertension,
obesity, cardiovascular disease and Hyperlipidemia[1]. Other prospective studies also showed
that the patients with diabetes in the early stage may be subject to abnormal echocardiogram
and their probabilities of suffering from heart failure in the lifetime and Q-wave and non-Q
wave myocardial infarction will be increased[1,2]. Early in 2000, American Heart Association
issued a statement that "diabetes is a cardiovascular disease" [3]and in 2007, with
reference to the joint guidelines concerning diabetes, pre-diabetes and cardiovascular
disease, European Society of Cardiology (ESC) and the European Diabetes Research Institute
(ESAD) clearly pointed out that hyperglycemia and cardiovascular disease (CVD) are closely
related and the danger of CVD can be raised notably for those whose blood glucose is normal
when fasting but tend to increase postprandially[4]. In the pathogenesis study of
cardiovascular complications of diabetes, the promotion of oxidative stress and declination
of the heart antioxidant reserves have close associations with the cardiovascular
complications in animal and human body[5]. A number of cytokines and inflammatory signaling
pathways are involved including tumor necrosis factor-α (TNF-α), high-sensitivity C-reactive
protein (HsCRP), adiponectin, IL-6, NF-κB[1,6]. Accordingly, this study analyzes the
echocardiography, high-sensitivity C-reactive protein and tumor necrosis factor-α of the
patients with diabetics in our hospital in order to find early warning indicators of the
cardiovascular complications of diabetes and provide prevention and treatment for
cardiovascular complications of diabetes.
Eligibility
Minimum age: 18 Years.
Maximum age: 95 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- In-patient or out-patient patients diagnosed with diabetes
- Over 18 years of age
- Gender-open
- The type of diabetes (type 1 or type 2) open
- Patients receive a written informed consent to participate in the trial
Exclusion Criteria:
- those diabetic patients with acute and chronic infection, high blood pressure,
special and Gestational diabetes Serious complications of heart, liver, lung, kidney
damage Malignant tumors
- Pregnant women and breast-feeding women
Locations and Contacts
Wu Qinan, master, Phone: 13452867542, Email: wqn11@126.com
Endocrine Department, the First Affiliated Hospital of the Third Military Medical University, chongqing 400038, China; Recruiting qinan wu, master, Phone: 02368765217, Ext: 86, Email: wqn11@126.com qinan wu, master, Sub-Investigator
Additional Information
Starting date: June 2007
Ending date: May 2010
Last updated: October 14, 2009
|